Location: Home
  • search
  • go
  • Relate News
  • 5/24/2018Karyopharm and Antengene Sign Exclusive License Agreement for Chinese ...
  • 5/23/2018What Chinese Consumers Want From Western Retailers
  • 5/23/2018WuXi Biologics to Invest to Build a S$80M Manufacturing Facility in Si...
  • 5/23/2018CNDA and NHC issue Joint Announcement for Optimization of Drug Evaluat...
  • 5/23/2018A-Share Listed Domestic Pharma Companies Report Q1/2018 Performance
  • 5/22/2018MOHRSS Publishes 2017 Human Resources and Social Security Statistical ...
  • 5/22/2018Takeda Sells Majority Stake in JV Techpool to Chinese Partners
  • 5/22/2018Bioasis and WuXi Biologics Enter Strategic Collaboration for Brain Can...
  • 5/22/2018Salubris Pharma, MedAllliance Enter Investment/Licensing Deal for Nove...
  • 5/20/2018SAMR Announces Major Initiative to Conduct Inspection over Unfair Comp...
  • 5/18/2018Recent Executive Moves
  • 5/16/2018Data Snapshot: Chinese Generic Drug Market
  • 5/16/2018CPIIC: Chinese Rep Hospital Drug Sales Growth Fell Sharply in 2017
  • 5/16/2018Snapshot of Chinese Pharmaceutical CRO Market
  • 5/14/2018CNDA Suspends Import of Sun Pharma's Injectable Drug
  • 5/14/2018SMEI: Urban Pubic Hospital Vaccine Consumption Up Sharply in Recent Ye...
  • 5/11/2018Recent Executive Moves
  • 5/11/2018Bayer Secures Another Indication for Eylea in China
  • 5/10/2018MSD Wins Chinese Approval of HCV New Drug ZEPATIER
  • 5/10/2018Trump's 'America First' Agenda on Drug Pricing Could Trigger Impacts A...
  • 5/8/2018NHC Minister Meets Merieux Foundation Delegation
  • 5/8/2018LipimetiX Licenses Apo E Mimetic Peptide Platform to Anji Pharma
  • 5/7/2018WuXi STA Changzhou Site Passes First U.S. FDA Inspection
  • 5/7/2018Chinese Pharma Performance Up in Q1 as 78 Listed Biopharma Sector Firm...
  • 5/4/2018NMPA Official: More Measures to Raise Review and Approval Efficiency
  • 5/4/2018Recent Executive Moves
  • 5/3/2018State Council Issues Official Policy for Internet + Healthcare Develop...
  • 5/3/2018Novartis Gains Chinese Approval for Its RVO Drug Lucentis (ranibizumab...
  • 5/2/2018CMBA Publishes Quality Control Standard of CAR-T for Public Comments
  • 4/30/2018IP Concerns Hamper China R&D
  • Page:177/371 Total number of articles:11124: [First][<<] [175] [176] [177] [178] [179] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group